Literature DB >> 516773

The intestinal phase hormone.

M J Orloff, P V Hyde, L D Kosta, R C Guillemin, R H Bell.   

Abstract

The existence of a stimulatory intestinal phase of gastric acid secretion has been suspected, but largely ignored, for many years. Recently, however, it has become clear that the intestinal phase plays an important role in acid production during digestion. The intestinal phase is of additional interest in relation to the profound gastric acid hypersecretion associated with portacaval shunt (PCS). Substantial evidence indicates that PCS-related gastric hypersecretion is due to unmasking of the intestinal phase by hepatic bypass of a humoral stimulant in portal blood that is normally degraded to a considerable extent by the liver. Studies in our laboratory during the past 12 years have provided strong physiologic evidence for humoral mediation of both the intestinal phase of gastric secretion and of PCS-related hypersecretion by a hormone that arises in the small intestine, particularly in the jejunum. Furthermore, our studies have demonstrated that this intestinal phase hormone (IPH) exists in humans as well as in dogs, rats, and pigs. Additionally, recent work by a number of investigators, as well as by our group, has provided convincing evidence that IPH is different from any of the known gastric stimulatory hormones. With these physiologic observations as a background, we have used a classical method for extracting acidic peptides to prepare a hog intestinal mucosa extract (HIME) that has all of the known physiologic properties of an IPH. Specifically, HIME contains a potent stimulant of gastric acid secretion that acts according to a linear dose-response relationship; that is not gastrin in any of its immunoassayable forms; that significantly augments the maximal acid secretory responses to pentagastrin, gastrin, CCK, and histamine; and that is substantially degraded by the liver, in contrast to gastrin and CCK. Efforts at isolating the gastric stimulatory substance in HIME suggest that it is a peptide of low molecular weight. Work directed at isolating IPH in pure form and identifying it is in progress.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 516773     DOI: 10.1007/bf01654753

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  103 in total

1.  Characteristics of intestinal phase of gastric secretion.

Authors:  S J Konturek; H Kaess; N Kwiecień; T Radecki; M Dorner; U Teckentrupp
Journal:  Am J Physiol       Date:  1976-02

2.  THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA.

Authors:  R A GREGORY; H J TRACY
Journal:  Gut       Date:  1964-04       Impact factor: 23.059

3.  INHIBITION OF GASTRIC ACID SECRETION BY SECRETIN AND BY ENDOGENOUS ACID IN THE DUODENUM.

Authors:  K G WORMSLEY; M I GROSSMAN
Journal:  Gastroenterology       Date:  1964-07       Impact factor: 22.682

4.  Gastric secretion in the fasting state and after antral stimulation in patients with cirrhosis and with portacaval shunts.

Authors:  J S CLARKE; R COSTARELLA; S WARD
Journal:  Surg Forum       Date:  1958

5.  Studies on the mechanisms in the duodenum inhibiting gastric secretion.

Authors:  W SIRCUS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1958-01

6.  Histidine metabolism after portacaval shunt in the rat.

Authors:  F A Reichle; M P Brigham; R R Tyson; G P Rosemond
Journal:  J Surg Res       Date:  1968-07       Impact factor: 2.192

7.  Effect of portacaval shunting on postprandial serum gastrin levels in dogs.

Authors:  B G Clendinnen; D D Reeder; B M Jackson; J H Miller; J C Thompson
Journal:  Surg Forum       Date:  1970

8.  Gastric secretagogues following portacaval shunting.

Authors:  W O Griffen; M Z Slesh; C S Mooney
Journal:  Surgery       Date:  1969-07       Impact factor: 3.982

9.  The intestinal phase of gastric secretion: a pharmacological profile of entero-oxyntin.

Authors:  L W Way; D W Cairns; C W Deveney
Journal:  Surgery       Date:  1975-06       Impact factor: 3.982

10.  Some properties shared by amino acids and entero-oxyntin.

Authors:  E C Mariano; A Beloni; J H Landor
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

View more
  2 in total

1.  Effect of a protein meal in stomach and jejunum on gastric secretory response to pentagastrin in cats.

Authors:  M Fernström; S Emås
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

2.  Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.

Authors:  H J Lenz; T Struck; H Greten; M A Koss; V E Eysselein; J H Walsh; J I Isenberg
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.